Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-10-04

FDA Approved: TERIPARATIDE — Original Application (Alvogen, Inc.)

View source ↗

Summary

The FDA approved the original application for teriparatide from Alvogen, enabling its use for osteoporosis treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Teriparatide (Teriparatide)

Snippet

ORIG AP for TERIPARATIDE (TERIPARATIDE)